Learn how clinical approaches to skin cancer prevention and sun safety are evolving based on updates from the 2026 Cutaneous Oncology Workshop.
In September 2026, the inaugural Dermatology Times NP/PA Connect Cutaneous Oncology Workshop took place in Tampa, Florida. This full-day educational program gathered advanced practice providers and dermatology clinicians to discuss evolving standards of care. The event focused heavily on skin cancer prevention, early detection, and the management of hereditary risk. Discussions highlighted a comprehensive care model that connects clinical vigilance with daily photoprotection.
The curriculum addressed the expanding role of advanced practice providers in modern dermatological settings. These professionals are increasingly responsible for recognizing risk factors, counseling patients, and determining when specialized evaluation is necessary. Faculty covered clinical and histopathologic risk features for basal cell carcinoma and cutaneous squamous cell carcinoma. They also reviewed risk patterns for melanoma and Merkel cell carcinoma.
This educational initiative demonstrates a shift toward comprehensive patient management. Rather than treating skin cancer care as a single screening or isolated procedure, the workshop promoted continuous engagement. Clinicians are learning to blend preventive education directly into routine patient appointments. This approach empowers patients to understand their own role in maintaining cellular health between clinical visits.
A major biological theme at the workshop was the management of actinic keratosis and field cancerization. Actinic keratoses are rough patches on the skin caused by extensive ultraviolet damage over time. Field cancerization refers to the broader area of sun-damaged skin surrounding these visible lesions. Clinicians discussed how targeting this wider zone of cellular damage is essential for effective prevention.
The related workshop report described cryosurgery as an option for isolated actinic keratosis lesions. However, field-directed options allow practitioners to treat the wider environment of compromised cells. These field-directed options include topical 5-fluorouracil, imiquimod, and diclofenac. Practitioners might also recommend photodynamic therapy or chemical peels for broader treatment.
Treatment decisions for actinic keratosis and field damage require careful balancing of practical variables. The workshop emphasized matching the chosen treatment to the specific lesion burden of the patient. Factors like efficacy, tolerability, cost, and patient preference all play a significant role. Patient adherence heavily influences the final clinical effectiveness of these localized therapies.
Because field treatments cause visible changes, setting proper expectations is a critical part of the process. Clinicians must counsel patients about expected local reactions to these treatments. Patients should anticipate temporary side effects like localized redness and crusting during the healing phase. Understanding these expected reactions helps patients remain compliant with their prescribed treatment timelines.
The workshop also detailed structured lesion assessment techniques for clinicians. Amy Spizuoco, DO, FAOCD, described dermoscopy as a valuable aid to clinical judgment. Her specific three-point checklist asks clinicians to evaluate asymmetry of color and structure in a suspicious spot. They also look for an atypical pigment network and distinct blue-white structures before examining disease-specific patterns.
While new assessment tools offer promise, the scientific uncertainty around several emerging practices remains high. The recap says faculty discussed gene-expression profiling and circulating tumor DNA as potential diagnostic tools. They noted that family history and distinct patterns of skin cancer may warrant consideration of genetic predisposition. However, the report explicitly says questions remain about their place in routine practice.
These advanced genetic tests are not yet established screening methods for the general public. Similarly, dermoscopy comes with strict boundaries regarding its clinical application. Spizuoco emphasized that dermoscopy should not be used to talk a clinician out of a biopsy when a lesion is concerning. It serves to inform a professional assessment, but it does not override clinical concern or eliminate the need for pathology. Readers should never use these professional checklists to diagnose their own skin lesions at home.
Oral supplements were also evaluated with firm clinical caveats during the event. The main workshop report noted discussions of oral nicotinamide as one potential prevention strategy. Yet, the coverage provided no specific dose, patient selection guidance, or overall efficacy estimate for this ingredient. The available literature from the event does not establish that oral nicotinamide is appropriate for every reader.
Another session reviewed different oral compounds and reinforced the necessity of traditional photoprotection. A separate report on the prevention session discussed oral Polypodium leucotomos, which is a distinct supplement from nicotinamide. This session explicitly cautioned that oral supplements should never replace topical sunscreen. The scientific consensus remains that supplements play a strictly supportive role in comprehensive skin protection protocols.
For those focused on maintaining long-term skin resilience, consistent daily habits remain the absolute foundation of care. Amit Om, MD, FACMS, discussed sunscreen use alongside protective clothing, shade, and avoiding peak UV exposure. He explained that inadequate application and a failure to reapply drastically reduce sunscreen efficacy in the real world. Upgrading to UPF clothing helps patients avoid two common problems: underapplication and missed reapplication.
The workshop coverage attributes practical advice to Om to consistently use SPF 30 or higher. He reinforced this foundational standard by stating, "Sunscreen is good. Period. We know that it prevents skin cancer." These comprehensive strategies for sun protection support both immediate health goals and long-term visible longevity. By blocking harmful ultraviolet rays, you effectively prevent the accelerated breakdown of cellular structures.
The American Academy of Dermatology provides similar clear parameters for the general public. The AAD recommends combining shade and protective clothing with broad-spectrum, water-resistant sunscreen of SPF 30 or higher. This should be applied to all uncovered skin, reapplied every two hours, and reapplied after swimming or sweating. The AAD confirms that daily sunscreen helps prevent skin cancer while also slowing the visible signs of skin aging.
Routine vigilance must always remain a collaborative effort with a certified medical professional. The AAD advises seeking prompt dermatologic care for a spot that differs from others, changes, itches, or bleeds. Early detection relies on a combination of consistent daily habits and timely professional review. Your daily beauty routine is strictly for preservation, but medical concerns always require professional pathology.
The clinical management of sun-damaged skin continues to shift from reactive procedures to comprehensive long-term care. As genetic risk tools and targeted field treatments become more refined, dermatological focus is moving toward early cellular intervention. How will future advancements in non-invasive imaging and preventive field therapies further bridge the gap between routine medical screening and proactive skin longevity?
Stay connected for research and practical guidance on skin, hair, collagen, nutrition and beauty longevity. Clear ideas for people who want to understand how appearance changes with age and make better-informed choices over time.
Understand your skin, hair and body better without chasing every new trend, treatment or promise.
explore the Blog
